|
US2019336572A1
|
|
Composition and method for oral delivery of stable formulations of cobra venom
|
|
WO2016145256A1
|
|
Use of components of cobra venom for treatment of chronic kidney disease
|
|
US2014030354A1
|
|
Composition and method for oral delivery of cobra venom
|
|
US2011118191A1
|
|
Crotoxin Administration for Cancer Treatment and Pain Relief
|
|
US2009209468A1
|
|
Alpha-neurotoxin proteins with anti-inflammatory properties and uses thereof
|
|
US2007148159A1
|
|
Use of crotoxin as an analgesic - CIP
|
|
US2006088858A1
|
|
Modified venom and venom components as anti-retroviral agents
|
|
US2006088843A1
|
|
Modified venom and venom components as anti-retroviral agents
|
|
US2006045875A1
|
|
Method of use of crotoxin as an anti-retroviral agent
|
